Media

Press Kit

Malin Media Pack

> Coming Soon

Reports & Presentations

CEO Letter to Shareholders

> download > go to Reports & Presentations page

Latest Press Releases

RNS Announcements

Investee Companies

Fri, 15 Jan 2021

Notice of EGM

Mon, 11 Jan 2021

Immunocore closes $75m Series C Financing

Mon, 11 Jan 2021

Kymab to be acquired by Sanofi

Mon, 21 Dec 2020

Update from CEO

Wed, 09 Dec 2020

Mycovia Reports Positive Topline Results

News Archive>

11 Jan 2021

Immunocore announces closing of $75.0 Million Series C round

11 Jan 2021

Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L

06 Jan 2021

Mycovia Pharmaceuticals Announces Positive Topline Results from its Third Phase 3 Clinical Trial (ultraVIOLET) of Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis

04 Jan 2021

Poseida Therapeutics to Participate in SternIR Virtual Corporate Access Event

18 Dec 2020

Poseida Therapeutics Added to NASDAQ Biotechnology Index

Media Contacts

Malin Media Contact

Tel: +353 (0)1 901 5717

mediarelations@malinplc.com
Ireland - Financial Media Contact

Powerscourt

Tel: +353 (0)1 536 0682

malin@powerscourt-group.com
UK - Financial Media Contact

Consilium Strategic Communications

Tel: +44 (0)20 3709 5700

malin@consilium-comms.com